OmniAb, Inc.

SEC filing

Biotechnology · Emeryville, CA

Form D on EDGAR

Amount raised$30Msold at filing

Total offering$30M

Investors in the raise15count reported to the SEC

FiledSep 10, 2025first sale Aug 26, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Carolyn R. BertozziDirector

Kurt W. GustafsonExecutive Officer

John W. HigginsDirector

Jennifer W. CochranDirector

Matthew W. FoehrExecutive Officer, Director

Charles W. BerkmanExecutive Officer

Philip J. GotwalsDirector

Steve R. LoveDirector

Steve R. CrouseDirector

Executive officers, directors and promoters as listed on the Form D.